Pure Global

Bacteriophage Therapy of Difficult-to-treat Infections - Trial NCT05498363

Access comprehensive clinical trial information for NCT05498363 through Pure Global AI's free database. This phase not specified trial is sponsored by Queen Astrid Military Hospital and is currently Completed. The study focuses on Bacterial Infections. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05498363
Completed
biological
Trial Details
ClinicalTrials.gov • NCT05498363
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Bacteriophage Therapy of Difficult-to-treat Infections
Bacteriophage Therapy of Difficult-to-treat Infections: a Retrospective, Observational Analysis of the First One Hundred Consecutive Cases Facilitated by a Belgian Consortium

Study Focus

Bacterial Infections

Bacteriophage therapy

Observational

biological

Sponsor & Location

Queen Astrid Military Hospital

Timeline & Enrollment

N/A

Jan 01, 2008

Dec 31, 2021

100 participants

Primary Outcome

Clinical improvement,Microbial eradication,Adverse reactions

Summary

A retrospective, observational analysis of the first one hundred consecutive cases of
 bacteriophage therapy of difficult-to-treat infections, facilitated by a Belgian consortium.

ICD-10 Classifications

Bacterial infection, unspecified
Bacterial, viral and other infectious agents
Other bacterial intestinal infections
Other bacterial diseases
Other specified bacterial intestinal infections

Data Source

ClinicalTrials.gov

NCT05498363

Non-Device Trial